Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TRPM7 is a unique bifunctional protein combining an ion channel with an intrinsic serine/threonine kinase. It functions as a nonselective cation channel permeable to Mg²⁺, Zn²⁺, and Ca²⁺, and its kinase domain modulates various signaling pathways. TRPM7 plays essential roles in embryonic development, divalent cation balance, immune responses, cell mobility, proliferation, differentiation, and neuronal/cardiovascular function. Dysregulation is implicated in hypomagnesemia, seizures, developmental delay, cancer, neuronal disorders, cardiovascular diseases, and immune dysfunctions, making it a potential drug target.
Modulation of ion channel activity and kinase signaling pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transient Receptor Potential Cation Channel, Subfamily M, Member 7 (TRPM7).